Stem Cell Therapeutic and Research Reauthorization Act of 2026
Sponsored By: Senator Reed, Jack [D-RI]
Introduced
Summary
Would reauthorize and modestly increase annual funding for the C.W. Bill Young Cell Transplantation Program and extend the Cord Blood Inventory through 2031. This bill would set specific yearly appropriation levels so federal support for these stem cell programs continues under the existing statutory framework.
Show full summary
- Families and patients: Keeps federal programs that support stem cell transplantation and cord blood resources funded through 2031, helping those programs continue to operate.
- Program managers and health systems: Sets the base appropriation at $31.0 million and provides $33.0 million per year for fiscal years 2027–2031, giving multi-year funding clarity for the C.W. Bill Young Cell Transplantation Program and extending the Cord Blood Inventory authorization through 2031.
*Would authorize $31.0 million in the base year and $33.0 million annually for FY2027–2031 for the transplantation program.*
Your PRIA Score
Personalized for You
How does this bill affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this bill and every other piece of legislation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Bill Overview
Analyzed Economic Effects
1 provisions identified: 1 benefits, 0 costs, 0 mixed.
More funding for stem cell transplants
If enacted, this bill would keep a $31,009,000 base appropriation for the C.W. Bill Young Cell Transplantation Program. It would add $33,009,000 for each fiscal year 2027 through 2031. The bill would also extend the Cord Blood Inventory program authorization from 2026 to 2031. These changes would take effect upon enactment and mainly help patients, transplant centers, and cord blood banks.
Sponsors & CoSponsors
Sponsor
Reed, Jack [D-RI]
RI • D
Cosponsors
Sen. Scott, Tim [R-SC]
SC • R
Sponsored 3/17/2026
Sen. Smith, Tina [D-MN]
MN • D
Sponsored 3/17/2026
Sen. Lankford, James [R-OK]
OK • R
Sponsored 3/17/2026
Roll Call Votes
No roll call votes available for this bill.
View on Congress.gov